Displaying 1–25 of 223 results for Paul Thomas, Senior Editor

Sort By Relevance Sort By Date
1 2 3 4 5 ...9

Tracing NIR's Trajectory for Bioprocess Monitoring

(Article)

By better combining and interpreting readily available data, biomanufacturing experts are improving control of fermentation and other processes, says Sartorius’ Roland Bienert.

Tracing NIR’s Trajectory for Bioprocess Monitoring

(Article)

By better combining and interpreting readily available data, biomanufacturing experts are gaining better control of fermentation and other processes, says Sartorius’ Roland Bienert

Tracing NIR’s Trajectory for Bioprocess Monitoring

(Article)

By better combining and interpreting readily available data, biomanufacturing experts are gaining better control of fermentation and other processes, says Sartorius’ Roland Bienert.

Soaring Innovation, Grounded Goals

(Article)

Readers recognize tools that break new ground but promise to improve efficiency

PharmaView: Single-Use Standards: What’s the Rush?

(Article)

Can standardization and innovation coexist?

A New Era in Handheld Raman Devices for Pharmaceutical Applications

(Article)

FDA’s John Kauffman describes the vast potential of portable Raman devices, even for those who are not trained spectroscopy experts.

Are Single-Use Standards Stuck? And Is That a Bad Thing?

(Article)

Efforts to enact meaningful standards for single-use bioprocessing technologies move at a snail's pace, with no clear path forward, experts say.

Town Hall: FDA Braces for PDUFA V, Possible Loss of Biosimilars Authority

(Article)

Janet Woodcock looks forward to having more cash and resources with new user fee legislation. Meanwhile, she raises concerns about the Agency’s authority over biosimilars should the Supreme Court strike down the Affordable Care Act.

PharmaView: The Future? Let's Get Pumped Up

(Article)

To survive, Steven Burrill tells Big Pharma, ignore the “gravel in the road” and embrace the disruption.

Pfizer Newbridge Powers Up

(Article)

Michael Donlon and Dermot Doran of Pfizer Newbridge discuss the challenges and success of the site’s YOU Have the Power project.

Bayer: Keeping Data Cold and Green

(Article)

An interview with Thomas Schilling on the company’s Green IT initiative.

Pharma Sustainability Is on a Roll

(Article)

Drug industry environmental stewardship projects are becoming more sophisticated and challenging. Here are examples from AstraZeneca, Bayer, DSM, Pfizer, and EMD Millipore

EMD Millipore: Giving and Receiving Single-Use Systems

(Article)

A talk with sustainability manager Johanna Jobin about the company's new product recycling initiative.

PharmaView: Carrots, Sticks, and CEOs

(Article)

Salary does not dictate motivation and performance.

Sartorius and G-Con: Bioprocess Cleanrooms Go Mobile

(Article)

A joint collaboration claims it has a “disruptive technology” that can be shipped anywhere, and used in any way. Does it raise the bar for future flexible facilities?

With a Full Range of Products, EMD Millipore Turns Its Attention to Solutions

(Article)

The company aims to leverage the expertise it has always had in-house, yet hadn’t fully capitalized on with the pharma industry, says VP Christophe Couturier.

PharmaView: Who Will Be Pharma's Kane Waselenchuk?

(Article)

As conventional ways of making drugs give way, we will seek out these people and value their brilliance.

Pharma Jobs Are (Still) Going to Carolina

(Article)

BioNetwork’s Doug Drabble says there are jobs throughout the state, though workers won't always relocate to take them.

Cleanroom Couture and Other Fashionable Products

(Article)

A look at what’s new for the cleanroom set.

Is It Time for Biopharma OpEx to Grow Up?

(Article)

New research indicates that biopharma manufacturers have a desire for operational excellence but are not using sophisticated methods that are commonplace in other industries.

Striving for a Better Prefilled Syringe

(Article)

West and Vetter look to meet the needs of parenteral manufacturers demanding new, safer syringe options.

PharmaView: Time Away from a Life in Big Pharma

(Article)

“It is worth having dreams,” and worth fulfilling them, says former Novartis employee Anna Kroczak.

Single-Use Systems in 2012: A Talk with Robert Repetto

(Article)

Pfizer director and PDA member Repetto discusses PDA’s upcoming technical report and other critical issues facing SUS.

Jobs and Salaries: Pharma's Professionals Piece Together the Future

(Article)

Our eighth annual Job Satisfaction and Salary Survey says the big picture is brighter, though not clearer.

Pharma Workers Enter the Era of Free Agency

(Article)

Tectonic shifts are changing the way pharma workers will view loyalty and employment, says Kelly Services’ Alan Edwards.

Sort By Relevance Sort By Date
1 2 3 4 5 ...9